This product is used for the treatment of colicky pain in biliary and urinary tract, bladder tenesmus, painful spasms in the stomach and intestines, spastic dysmenorrhea, and control of spastic pain during and after instrumental examination.
Analgin passes the placental barrier, and should there fore be used during pregnancy, especially during the first 3 months and the last 6 weeks, only after careful consideraton of the indications. Analgin was considered to be unsafe in patients with acute porphyria.
Analgin produced an exacerbation of dyspnoea, cyanosis and respiratory arrest, Agranulocytosis presumed to be due to Analgin Allergic skin reactions.
Administration: It may be given by intramuscular or intravenous injection in doses of 0.5g to 1.0g.
Precautions & Warning:
It contains Metamizole /Analgin which may cause agranulocytosts.
To be sold on prescription of registered medical practitioner only.
Store below 25℃. Protect from moisture. Keep out of reach of children.